Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Phase Holographic Imaging PHI AB's 3-Year RORE % for the quarter that ended in Oct. 2025 was -29.47%.
FRA:L5W's 3-Year RORE % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -4.03
vs FRA:L5W: -29.47
Phase Holographic Imaging PHI AB (FRA:L5W) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Phase Holographic Imaging PHI AB 3-Year RORE % Related Terms
Phase Holographic Imaging PHI AB 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phase Holographic Imaging PHI AB 3-Year RORE % Chart
FRA:L5W vs ABT, BSX, SYK: 3-Year RORE % Comparison
For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phase Holographic Imaging PHI AB 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Phase Holographic Imaging PHI AB's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Oct. 2025 and 3-year before.
Phase Holographic Imaging PHI AB (FRA:L5W) has a 3-Year RORE % of -29.47 as of Oct. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Phase Holographic Imaging PHI AB and its competitors.
Is Phase Holographic Imaging PHI AB's 3-Year RORE % too high?
Phase Holographic Imaging PHI AB's current 3-Year RORE % is -29.47.
How does Phase Holographic Imaging PHI AB's 3-Year RORE % compare to ABT and BSX?
Phase Holographic Imaging PHI AB's 3-Year RORE % of -29.47 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Phase Holographic Imaging PHI AB and its competitors. Phase Holographic Imaging PHI AB's current 3-Year RORE % is -29.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current 3-Year RORE % of -29.47. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current 3-Year RORE % is -29.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current 3-Year RORE % is -29.47 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phase Holographic Imaging PHI AB Business Description
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L5W has been successfully added to your 
